AI Use & Limitations

"Kairo" is the AI assistant you may have spoken with on this website. This page tells you exactly what Kairo is, how it works, what it can do well, and — more importantly — what it cannot. We err on the side of full disclosure rather than marketing copy.

1. What Kairo is

Kairo is an AI assistant that lets visitors to immunosync.com.au ask questions, by voice or by typing, about ImmunoSync's platform, our clinical evidence, our partnerships, and our team. Kairo is implemented as a thin client (the floating orb you see on the page) that streams audio and text in real time to Google Cloud's Vertex AI service, where a generative model produces the response and grounds it against a curated corpus of our own documents.

Kairo's purpose is to be a helpful first point of contact — the equivalent of a knowledgeable receptionist who has read all our materials. Kairo is not the team itself, and Kairo is not a substitute for speaking with the team.

2. How Kairo works (in plain language)

• When you click the orb, your browser opens a secure WebSocket connection directly to Google's Vertex AI infrastructure (in the United States or, where available, an Australian region).
• Your microphone audio streams up to Vertex AI in real time. The model decodes the speech, decides on a response, retrieves relevant passages from our document corpus, and streams audio (Charon's voice) back down the same connection for playback.
• The orb you see is purely visual: it doesn't transcribe locally, it doesn't keep a recording, and it doesn't store your conversation.
• Kairo can also accept typed text via a "Type instead" mode, which sends the same kind of conversational turn through the same connection.
• If you ask for a follow-up — Investor Pack, demo, partnership conversation — Kairo will collect contact details from you, read them back for confirmation, and pass them to our team's lead-capture system. See clause 6 below.

3. Things Kairo is good at

• Summarising what's in our published documents — particularly the proof-of-principle trial, the platform architecture, the team, and the partnership pathways.
• Routing visitors to the right next step (a demo, the Investor Pack, an introduction to the relevant person on the team).
• Answering basic factual questions sourced from our own materials, with citation back to the source document.
• Holding a natural conversation over a few minutes, including remembering what you've said earlier in the session.

4. Things Kairo is not, and is not for

4.1 Not medical advice

Kairo is not a registered health practitioner and Kairo's responses are not medical advice. Nothing Kairo says should be relied on as a diagnosis, recommendation about a specific patient's treatment, or guidance about whether any particular therapy is appropriate for any particular individual. If you are a clinician with a clinical question or a patient or family member with a medical concern, please speak with a qualified healthcare professional. Kairo will redirect you accordingly if you start sharing personal health information.

4.2 Not legal or financial advice

Kairo is not a lawyer, accountant, financial adviser, or licensed investment professional. Kairo's responses are not legal advice, not tax advice, and not financial product advice within the meaning of the Corporations Act 2001 (Cth) or any other law. If you need professional advice, consult an appropriately licensed adviser.

4.3 Not an offer to invest

Kairo may discuss our commercial thesis, the structure of our platform, our regulatory pathway, and how to request follow-up from our team. None of that is an offer of securities or an invitation to subscribe. Any binding commercial relationship is established only by way of a definitive written agreement executed by the Managing Director of Lifecycle Oncology Pty Ltd. The forward-looking-statement provisions in our Terms of Use apply in full to anything Kairo says about the company, the platform, our forecasts, and our intellectual-property strategy.

4.4 Not authoritative

Even when Kairo cites a specific document, you should treat the cited passage as the source of truth and Kairo's paraphrase as just that — a paraphrase. Where the answer matters, go to the original document.

5. AI limitations you should be aware of

5.1 Hallucinations

Generative AI can produce content that is incorrect or made up. This includes fabricated authors, fabricated dates, fabricated quantitative claims, and fabricated quotations from documents that do not exist. Retrieval-augmented grounding (asking the model to consult our document corpus before answering) reduces the rate of fabrication but does not eliminate it. Treat any factual or quantitative claim from Kairo as something to verify, not something to cite.

5.2 Forward-looking statements

Some of Kairo's answers will involve forward-looking statements — statements about future plans, anticipated regulatory milestones, anticipated commercial outcomes, future trial designs, partnership pipelines, and similar. These are subject to substantial risk and uncertainty. They should be read together with the forward-looking-statement provisions in our Terms of Use. None of them is a guarantee of future performance.

5.3 Stale information

Kairo's knowledge base is updated periodically by us, but we do not guarantee that any particular fact is current as of the moment you ask. Regulatory status, partner announcements, team composition, trial enrolment numbers, and similar facts can change between Kairo updates. Always check directly with us for time-sensitive details.

5.4 Speech recognition errors

Spoken-language AI can mishear words — particularly proper names, drug names, gene symbols, and technical jargon. If a question or answer turns on a precise term, please confirm the spelling in writing or via email.

5.5 No professional relationship

Speaking with Kairo does not create a doctor–patient, attorney–client, fiduciary, advisory, or other professional relationship between you and Lifecycle Oncology Pty Ltd or its officers. Conversations with Kairo are not subject to legal privilege, medical confidentiality, or any equivalent protection.

6. Lead capture (when you ask for follow-up)

If you ask Kairo for a follow-up — for example, an Investor Pack, a demo, or a partnership discussion — Kairo will collect the contact details needed to make that follow-up possible (an email address at minimum, plus optionally name, company, role, and a brief summary of your interest). Before sending those details to our team:

1. Kairo will read them back to you and ask you to confirm.
2. Only after you confirm will Kairo invoke the lead-capture function, which writes the captured details to a private Google Sheet controlled by Lifecycle Oncology Pty Ltd.
3. You will receive a brief acknowledgement that the team will be in touch shortly.

You can decline to share any of the optional fields. If you do not give an email address, Kairo cannot complete a follow-up — but you can always email us directly at daniel@immunosync.com.au.

7. Data flow and what's stored

• Voice and text in transit: streamed in real time to Google Cloud's Vertex AI Multimodal Live service for processing.
• Voice not retained by us: we do not record or persist your audio. Conversation context exists only for the duration of your active session and is destroyed when you close the orb.
• Lead-capture data is retained: once you have confirmed and Kairo has captured a lead, the structured summary is written to our Google Sheet and retained until the relevant business relationship has been concluded or you ask us to delete it.
• Sub-processors: Google LLC (Vertex AI), Netlify Inc. (hosting and serverless functions), Google Workspace (Sheets storage). See our Privacy Policy for details and locations.

8. Escalating to a human

You can leave Kairo at any time and contact us directly. The team is reachable at:

daniel@immunosync.com.au
Daniel Trenton, Managing Director, Lifecycle Oncology Pty Ltd

If something Kairo said feels wrong, misleading, or simply unclear, please get in touch. We use those reports both to fix immediate misunderstandings and to improve the system over time.

9. Reporting concerns

If you believe Kairo has produced content that is misleading, defamatory, infringes a third-party right, contravenes Australian Consumer Law, or otherwise causes harm, please report it to daniel@immunosync.com.au. We will investigate and respond within a reasonable time.

10. Changes to this notice

We may update this notice as Kairo's capabilities evolve, as our underlying providers change, or as relevant regulation matures. The "Last updated" date at the top reflects the latest revision.

11. Acknowledgment

By using Kairo and this Website, you acknowledge and accept the following:

• You have read, understood, and accept the limitations of Kairo and the AI assistant model described above, including the inherent risks of error, omission, "hallucination", forward-looking uncertainty, stale information, and speech-recognition errors.
• You will not rely on any factual, scientific, regulatory, financial, commercial, or medical claim made by Kairo without independent verification against an authoritative source.
• Your use of Kairo does not create any professional, fiduciary, advisory, doctor–patient, or attorney–client relationship between you and Lifecycle Oncology Pty Ltd.
• Your continued use of Kairo and the Website constitutes your agreement to be bound by our Terms of Use, our Privacy Policy, and the limitations set out in this notice.

If you do not agree to any of the above, please do not use Kairo or this Website.

12. Related documents

• Terms of Use — the contractual basis for using this Website and Kairo.
• Privacy Policy — full description of how personal information is handled.
• Cookie Policy — what cookies and storage we use.